<DOC>
	<DOCNO>NCT01804231</DOCNO>
	<brief_summary>Evaluate impact hybrid 18F-Fluoro-choline ( 18F-FCH ) PET/MRI image clinical management men suspect recurrent prostate cancer post prostatectomy radiotherapy . We hypothesize hybrid image incorporate 18F-FCH PET/MRI image feasible lead change management decision among men re-staged suspected prostate cancer recurrence post-surgery radiation potentially eligible local salvage therapy .</brief_summary>
	<brief_title>Prospective Study Using Hybrid PET/MRI Evaluate Men With Suspected Recurrence Following Treatment Prostate Cancer</brief_title>
	<detailed_description>The study non-randomized , prospective study men suspect local recurrence prostate cancer post-prostatectomy radiation negative bone CT scan . Hybrid PET/MRI use 18F-FCH obtain consensus stag report generate attend clinician . Clinical management questionnaire complete study investigator obtain pre post image order gauge impact hybrid image clinical decision making .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Prostate cancer rise prostate specific antigen ( PSA ) post prostatectomy radiotherapy Suspected recurrence base PSA rise measure 3 occasion least 3 month apart absolute PSA &gt; 0.2 ng/mL Bone scan CT scan abdomen pelvis negative metastatic disease Evidence metastatic disease Contradiction 18FFCH PET scan Contraindication MRI</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>PET</keyword>
	<keyword>MRI</keyword>
	<keyword>Hybrid</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Fluorocholine</keyword>
</DOC>